Shin H, Hua J, Li H
Front Oncol. 2023; 13:1182727.
PMID: 37234978
PMC: 10206257.
DOI: 10.3389/fonc.2023.1182727.
Meyer L, Hermiston M
Cancer Drug Resist. 2022; 2(2):313-325.
PMID: 35582725
PMC: 8992636.
DOI: 10.20517/cdr.2019.11.
Pawel K, Maria Malgorzata S
Int J Mol Sci. 2022; 23(2).
PMID: 35055016
PMC: 8777692.
DOI: 10.3390/ijms23020830.
Mackowska N, Drobna-Sledzinska M, Witt M, Dawidowska M
Int J Mol Sci. 2021; 22(3).
PMID: 33573325
PMC: 7866817.
DOI: 10.3390/ijms22031388.
Drobna M, Szarzynska B, Jaksik R, Sedek L, Kuchmiy A, Taghon T
Cells. 2020; 9(5).
PMID: 32380791
PMC: 7290785.
DOI: 10.3390/cells9051137.
The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL.
Tavakoli Shirazi P, Eadie L, Heatley S, Hughes T, Yeung D, White D
Br J Cancer. 2019; 122(4):455-464.
PMID: 31792348
PMC: 7028932.
DOI: 10.1038/s41416-019-0647-7.
Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia.
Sharma N, Nickl C, Kang H, Ornatowski W, Brown R, Ness S
Cancer Sci. 2019; 110(6):1931-1946.
PMID: 30974024
PMC: 6549933.
DOI: 10.1111/cas.14021.
Impact of SNPs on methylation readouts by Illumina Infinium HumanMethylation450 BeadChip Array: implications for comparative population studies.
Daca-Roszak P, Pfeifer A, Zebracka-Gala J, Rusinek D, Szybinska A, Jarzab B
BMC Genomics. 2015; 16:1003.
PMID: 26607064
PMC: 4659175.
DOI: 10.1186/s12864-015-2202-0.
Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia.
Zhang C, Zhong J, Stucky A, Chen X, Press M, Zhang X
Clin Epigenetics. 2015; 7:117.
PMID: 26543507
PMC: 4634719.
DOI: 10.1186/s13148-015-0151-8.
Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia.
Gabriel A, Lafta F, Schwalbe E, Nakjang S, Cockell S, Iliasova A
Epigenetics. 2015; 10(8):717-26.
PMID: 26237075
PMC: 4622588.
DOI: 10.1080/15592294.2015.1061174.
PHF6 Degrees of Separation: The Multifaceted Roles of a Chromatin Adaptor Protein.
Todd M, Ivanochko D, Picketts D
Genes (Basel). 2015; 6(2):325-52.
PMID: 26103525
PMC: 4488667.
DOI: 10.3390/genes6020325.
Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways.
Macdonald I, Hathaway N
Immunol Cell Biol. 2014; 93(3):261-70.
PMID: 25533290
DOI: 10.1038/icb.2014.105.
Gene expression profiling of the DNMT3A R882 mutation in acute leukemia.
Huang X, Ma D, Dong W, Li P, Lu T, He N
Oncol Lett. 2013; 6(1):268-274.
PMID: 23946816
PMC: 3742503.
DOI: 10.3892/ol.2013.1347.
Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia.
Borssen M, Palmqvist L, Karrman K, Abrahamsson J, Behrendtz M, Heldrup J
PLoS One. 2013; 8(6):e65373.
PMID: 23762353
PMC: 3675104.
DOI: 10.1371/journal.pone.0065373.
Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia.
DiNardo C, Gharibyan V, Yang H, Wei Y, Pierce S, Kantarjian H
Am J Hematol. 2013; 88(9):784-9.
PMID: 23757320
PMC: 3947930.
DOI: 10.1002/ajh.23511.
